Metabolic Dysfunction-Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Proposed Stepwise Approach

被引：2
|
作者：
Solitano, Virginia [1 ,2 ]
Moschetta, Antonio [3 ,4 ]
机构：
[1] Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Bari, Italy
[4] INBB Natl Inst Biostruct & Biosyst, Rome, Italy
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 02期
关键词：
D O I：
10.1016/j.cgh.2023.08.019
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：215 / 218
页数：4
相关论文
共 50 条
  • [31] Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease
    Ni, Keying
    Meng, Lina
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
  • [32] Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
    Cherubini, Alessandro
    Della Torre, Sara
    Pelusi, Serena
    Valenti, Luca
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (12) : 1126 - 1136
  • [33] Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Scarpellini, Emidio
    Scarcella, Marialaura
    Tack, Jan F.
    Scarlata, Giuseppe Guido Maria
    Zanetti, Michela
    Abenavoli, Ludovico
    ANTIOXIDANTS, 2024, 13 (11)
  • [34] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [35] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [36] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [37] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [38] A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease
    Ramos, Maria Jimenez
    Kendall, Timothy J.
    Drozdov, Ignat
    Fallowfield, Jonathan A.
    ANNALS OF HEPATOLOGY, 2024, 29 (02)
  • [39] Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease
    Righetti, Riccardo
    Cinque, Felice
    Volpe, Maria Teresa
    Sebastiani, Giada
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (07) : 303 - 313
  • [40] Metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with Inflammatory Bowel Disease (IBD). A prospective single-center study
    Pastras, P.
    Papantoniou, K.
    Tsounis, E.
    Kanaloupitis, S.
    Aggeletopoulou, I
    Geramoutsos, G.
    Sotiropoulos, C.
    Zisimopoulos, K.
    Thomopoulos, K.
    Theocharis, G.
    Triantos, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2289 - i2289
12345